Staphylococcus aureus carriage among GPs in the Netherlands

British Journal of General Practice

Volumn 60, Issue 581, 2010, Pages 902-906

  Rijnders, Michelle I A ^a   Nys, Sita ^a   Driessen, Christel ^a   Hoebe, Christian J P A ^a   Hopstaken, Rogier M ^b   Oudhuis, Guy J ^a   Timmermans, Arno ^c   Stobberingh, Ellen E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Foundation of Primary Health Care Centres Eindhoven   (Netherlands)

^c DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

Antibiotic resistance; General practitioners; Staphylococcus aureus

Indexed keywords

CEFACLOR; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CROSS-SECTIONAL STUDY; GENERAL PRACTITIONER; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; NORMAL HUMAN; NOSE; OBSERVATIONAL STUDY; STAPHYLOCOCCUS AUREUS;

CARRIER STATE; DRUG RESISTANCE, MICROBIAL; EPIDEMIOLOGIC METHODS; FUSIDIC ACID; GENERAL PRACTITIONERS; HUMANS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 78650547898     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X544078     Document Type: Article

References (28)

1. Hoban DJ. Antibiotics and collateral damage. Clin Cornerstone 2003; Suppl 3:S12-20.
2. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med 2008; 121(4): 258-264.
3. Sjolund M, Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. ScandJ Infect Dis 2008; 40(11-12): 894-898.
4. Mulqueen J, Cafferty F, Cormican M, et al. Nasal carriage of meticillin-resistant Staphylococcus aureus in GPs in the West of Ireland. Br J Gen Pract 2007; 57(543): 811-813.
5. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008; 8(5): 289-301.
6. Isenberg HD. Essential procedures for clinical microbiology. Washington, DC: ASM Press, 1998.
7. CLSI, editor. Performance standards for antimicrobial susceptibility testing. Pennsylvania: Clinical and Liboratory Standards Institute, 2007.
8. Toma E, Barriault D, Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol 1995; 33(7): 1712-1715.
9. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990; 28(3): 608-609.
10. O'Sullivan MV, Cai Y, Kong F, et al. Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp, J Clin Microbiol 2006; 44(11): 4072-4076.
11. Nulens E, Stobberingh EE, van Dessel H, et al. Molecular characterization of Staphylococcus aureus bloodstream isolates collected in a Dutch University Hospital between 1999 and 2006. J Clin Microbiol 2008; 46(7): 2438-2341.
12. Katayama Y, Robinson DA, Enright MC, Chambers HF. Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol 2005; 43(5): 2380-2383.
13. Nubel U, Roumagnac P, Feldkamp M, et al. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2008; 105(37): 14130-14135.
14. Coello R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13(1): 74-81.
15. Batra R, Eziefula AC, Wyncoll D, Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008; 34(9): 1703-1706.
16. Blok HE, Troelstra A, Kamp-Hopmans TE, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003; 24(9): 679-685.
17. Stichting Werkgroep Antibiotica Beleid. Nethmap: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Amsterdam, SWAB, 2008.
18. Donker GA, Deurenberg RH, Driessen Q et al. The population structure of Staphylococcus aureus among general practice patients from The Netherlands. Clin Microbiol Infect 2009; 15(2): 137-143.
19. Kluytmans J, van Belkum A, Verbragh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Micrabbl Rev 1997; 10(3): 505-520.
20. Wiersma TJ, Boukes FS, Geijer RMM, Goudswaard AN. NHG-Standaarden voor de huisarts 2008. Utrecht: Bohn Stafleu Van Loghum, 2007. [In Dutch]
21. Koning S, van Suijlekom-Smit LW, Nouwen JL, et al. Fusidic add cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ 2002; 324(7331): 203-206.
22. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50(6): 873-876.
23. O'Neill AJ, Larsen AR, Skov R, et al. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007; 45(5): 1505-1510.
24. Vivoni AM, Diep BA, de Gouveia Magalhaes AC, et al. Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital; identification of international circulating lineages. J Clin Microbiol 2006; 44(5): 1686-1691.
25. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol. 2008; 8(6): 747-763.
26. Melles DC, Tenover FC, Kuehnert MJ, et al. Overlapping population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American mdividuals, J Clin Microbiol 2008; 46(1): 235-241.
27. Rijnders MIA, Deurenberg RH, Boumans ML, et al. Flucloxacillin, still tlie empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands. J Antimicrob Chemother 2009; 64(5): 1029-1034.
28. Friedrich AW, Witte W, Harmsen D, et al. SeqNet.org: a European laboratory network for sequence-based typing of microbial pathogens. Euro Surveill. 2006; 11 (2): 2874. http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=2874 (accessed 22 Apr 2010).